{"id":"mometasone-furoate-intranasal-application","safety":{"commonSideEffects":[{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Pharyngitis"},{"rate":null,"effect":"Epistaxis"},{"rate":null,"effect":"Nasal irritation"}]},"_chembl":{"chemblId":"CHEMBL1161","moleculeType":"Small molecule","molecularWeight":"521.44"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"As a glucocorticoid, mometasone furoate binds to glucocorticoid receptors in nasal tissue, leading to decreased production of inflammatory cytokines, chemokines, and adhesion molecules. This reduces recruitment and activation of inflammatory cells (eosinophils, mast cells, T cells) in the nasal mucosa, thereby alleviating symptoms of allergic and non-allergic rhinitis.","oneSentence":"Mometasone furoate is a corticosteroid that reduces inflammation in the nasal passages by suppressing immune cell activity and inflammatory mediator release.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:55:42.512Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Allergic rhinitis"},{"name":"Non-allergic rhinitis"},{"name":"Nasal polyps (adjunctive therapy)"}]},"trialDetails":[{"nctId":"NCT05505214","phase":"PHASE2","title":"Topical Steroids & Bacterial Decolonization for Radiation Dermatitis","status":"WITHDRAWN","sponsor":"Montefiore Medical Center","startDate":"2023-09-01","conditions":"Radiation Dermatitis","enrollment":""},{"nctId":"NCT02557269","phase":"PHASE4","title":"4\"S\" - Seasonal Symptoms Suppression Study","status":"UNKNOWN","sponsor":"Association Asthma, Bulgaria","startDate":"2015-05","conditions":"Seasonal Allergic Rhinitis","enrollment":60}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Nasonex"],"phase":"marketed","status":"active","brandName":"Mometasone furoate - intranasal application","genericName":"Mometasone furoate - intranasal application","companyName":"Association Asthma, Bulgaria","companyId":"association-asthma-bulgaria","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Mometasone furoate is a corticosteroid that reduces inflammation in the nasal passages by suppressing immune cell activity and inflammatory mediator release. Used for Allergic rhinitis, Nasal polyps, Chronic rhinosinusitis.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}